IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Sanofi-Aventis Acquires Pfizer’s Insulin Facility in Germany

10:37 AM MDT | June 12, 2009 | DEEPTI RAMESH

Sanofi-Aventis (Paris) says it has acquired one of the world’s largest insulin plants at Frankfurt, Germany, from Pfizer for €30 million. Sanofi-Aventis aims to strengthen its insulin production capacities with the acquisition. The deal includes buildings, equipment, machinery, and some existing contracts, Sanofi-Aventis says. The transaction is expected to close in the next few weeks. “The strong increase in demand for our insulins, especially Lantus, drives us to considerably extend our production capacities,” says Martin Siewert, general...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa